Efficacy and safety of low‐dose imatinib in an elderly patient with mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR‐ABL1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of low‐dose imatinib in an elderly patient with mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR‐ABL1

Published:2021-05 Issue:5 Volume:9 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Okayama Yusuke¹²,Takakuwa Teruhito¹²^ORCID,Otomaru Ippei¹,Horiuchi Mirei¹,Miura Akiko¹,Araki Taku¹,Fujitani Yotaro¹,Yamamura Ryosuke¹

Affiliation:

1. Department of Hematology Osaka Saiseikai Nakatsu Hospital Osaka Japan

2. Department of Hematology Graduate School of Medicine Osaka City University Osaka Japan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.4126

Reference16 articles.

1. Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and Pitfalls

2. Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification

3. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

4. Outcome of biphenotypic acute leukemia;Killick S;Haematologica,1999

5. Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dasatinib/imatinib;Reactions Weekly;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP